Prelude Capital Management’s iShares US Medical Devices ETF IHI Stock Holding History

Prelude Capital Management’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$390K	Buy	+7,890	New	+$401K	0.03%	633
2019 Q4	–	Sell	-2,700	Closed	-$111K	–	2067
2019 Q3	$111K	Sell	2,700 -540	-17%	-$22.1K	0.01%	915
2019 Q2	$130K	Buy	3,240 +480	+17%	+$18.2K	0.01%	861
2019 Q1	$107K	Buy	+2,760	New	+$100K	0.01%	908

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Prelude Capital Management's IHI Position: Q2 2026 in Review

Prelude Capital Management opened a new position in iShares US Medical Devices ETF (IHI) in Q2 2026: 7,890 shares worth $390K. The stake represents 0.03% of the portfolio and ranks #633 among its holdings. This is a return to the name: Prelude Capital Management previously reported a position in IHI as recently as Q3 2019.

Prelude Capital Management first reported a position in IHI in Q1 2019 and has held it in 4 quarters since. 503 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

Prelude Capital Management held 7,890 shares of iShares US Medical Devices ETF worth $390K as of Q2 2026.
iShares US Medical Devices ETF was a new Prelude Capital Management position in Q2 2026.
iShares US Medical Devices ETF made up 0.03% of Prelude Capital Management's portfolio in Q2 2026, its #633 holding.
Prelude Capital Management first reported a position in iShares US Medical Devices ETF in Q1 2019 and has held it in 4 quarters since.
503 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.